- Research article
- Open Access
- Open Peer Review
The etiology of acute meningitis and encephalitis syndromes in a sentinel pediatric hospital, Shenzhen, China
BMC Infectious Diseasesvolume 19, Article number: 560 (2019)
Acute meningitis and encephalitis syndromes (AMES) is a severe neurological infection which causes high case fatality and severe sequelae in children. To determine the etiology of childhood AMES in Shenzhen, a hospital-based study was undertaken.
A total of 240 cerebrospinal fluid (CSF) samples from 171 children meeting the case definition were included and screened for 12 common causative organisms. The clinical data and conventional testing results were collected and analyzed. Whole genome sequencing was performed on a Neisseria meningitidis isolate.
A pathogen was found in 85 (49.7%) cases; Group B Streptococcus (GBS) was detected in 17 cases, Escherichia coli in 15, Streptococcus pneumoniae in 14, enterovirus (EV) in 13, herpes simplex virus (HSV) in 3, N. meningitidis in 1, Haemophilus influenzae in 1, and others in 23. Notably, HSV was found after 43 days of treatment. Twelve GBS and 6 E. coli meningitis were found in neonates aged less than 1 month; 13 pneumococcal meningitis in children aged > 3 months; and 12 EV infections in children aged > 1 year old. The multilocus sequence typing of serogroup B N. meningitidis isolate was ST-3200/CC4821. High resistance rate to tetracycline (75%), penicillin (75%), and trimethoprim/sulfamethoxazole (75%) was found in 4 of S. pneumoniae isolates; clindamycin (100%) and tetracycline (100%) in 9 of GBS; and ampicillin (75%) and trimethoprim/sulfamethoxazole (67%) in 12 of E. coli.
The prevalence of N. meningitidis and JEV was very low and the cases of childhood AMES were mainly caused by other pathogens. GBS and E. coli were the main causative organisms in neonates, while S. pneumoniae and EV were mainly found in older children. HSV could be persistently found in the CSF samples despite of the treatment. A better prevention strategy for GBS, the introduction of pneumococcal vaccine, and incorporation of PCR methods were recommended.
Acute meningitis and encephalitis syndromes (AMES) is a severe neurological infection which causes high case fatality and severe sequelae including hearing loss and cognitive deficit [1, 2]. Children under the age of 5 years old are the main group at risk and the young infants below 2 months old have the highest incidence [2, 3].
A broad range of organisms are responsible for bacterial meningitis, including Streptococcus pneumoniae, Haemophilus influenzae, Group B Streptococcus (GBS), Neisseria meningitidis, and Listeria monocytogenes . Other causative organisms such as herpes simplex virus (HSV), enterovirus (EV), and Varicella zoster virus (VZV) are associated with aseptic meningitis and encephalitis .
N. meningitidis and Japanese encephalitis virus (JEV) are the only two causative agents included in the National Infectious Diseases Surveillance System in China. However, due to the nationwide vaccination program of serogroup A and serogroup A plus C meningococcal, and JEV vaccines, the incidence of AMES caused by N. meningitidis and JEV has decreased markedly . The annual incidence of Japanese encephalitis (JE) declined from 0.9489/100,000 in 2000 to 0.12/100,000 in 2011 [6, 7]. The annual incidence of meningococcal meningitis declined from 0.18/100,000 in 2005 to 0.02/100,000 in 2010 and a switch of prevalent serogroups was observed after integration of meningococcal polysaccharide vaccine into the national Expanded Program on Immunization (EPI) in 2008 [8, 9]. However, little is known about the frequency of other causative pathogens or the disease burden of AMES in China.
A large population-based surveillance for bacterial meningitis during 2006 and 2009 was undertaken in four cities and it estimated the annual incidence (per 100,000 population) of probable bacterial meningitis in the children < 5 years old ranged from 6.95 to 22.30 . A pathogen was identified in a small proportion of tested cases (2.2%) and the cause of other cases remained undefined . A relative low detection rate (22.6%) was also observed in another Chinese study in which serological assays were used for testing viruses .
PCR had great advantage over conventional methods and the yield for detection of bacterial pathogens increased by 20 to 85% in a study conducted in Brazil , and it was widely used for detecting the causative pathogens of AMES [11, 12].
Due to the large geographical and economic variation in China, the prevalence of vector-borne diseases such as JE , immunization rate, and healthcare quality varied in different regions. Apart from the free vaccines, the coverage of others including pneumococcal and H. influenzae type b vaccine would be higher in the developed cities than that in other regions. As a metropolis with over 12 million population and China’s open door to the world, it is urgent to understand the etiology of AMES in Shenzhen, and then provide basis for introducing effective policies for immunization and prevention. Here we undertook a prospective study in a sentinel pediatric hospital which covered 426,000 outpatients and 77,000 inpatients annually to determine the etiology of childhood AMES in Shenzhen and extensive testing was conducted.
Shenzhen Children’s Hospital (SCH) was chosen as the sentinel hospital. It serves as a referral center in the field of pediatric diseases and treats over 60% of childhood AMES cases in Shenzhen each year.
Possible AMES were defined based on clinical manifestations (altered consciousness that persisted for longer than 24 h), and with two or more of the following: fever (≥38°C) or the history of fever during the presenting illness; abnormal neuroimaging findings; and CSF pleocytosis (more than four white blood cells per μL). Childhood outpatients and inpatients who met the criteria, including those transferred from other centers in this region were recruited during June, 2015 and October, 2018. Only the possible cases whose guardians agreed to participate in this study and who had enough volume of CSF samples for tests were enrolled in this study. Patients with a different final diagnosis (e.g., tumor and epilepsy) were excluded (Fig. 1).
Of the enrolled patients, their CSF samples after the routine tests were collected, stored in − 80 °C and transported to Futian District Center for Disease Control and Prevention for PCR examination once every 5 workdays. The demographic data, blood and CSF test results including Gram stain and culture results were collected. The use of antimicrobials when collecting CSF samples, route of admission, clinical symptoms, treatment and outcome were also collected.
The isolates from blood and CSF samples were collected and subjected to antimicrobial susceptibility testing using Vitek 2 Compact system (bioMerieux, France). Reference strains were used as controls according to the guideline. Disc diffusion method was used for testing the antibiotic susceptibility for N. meningitidis according to the Clinical and Laboratory Standards Institute (CLSI, 2016) M100 guideline. S. pneumoniae (ATCC 49619) and E. coli (ATCC 25922) were used as controls for disk diffusion method. The susceptibilities for the tested antimicrobials were classified as resistant, intermediate, and susceptible according to the guideline (CLSI, 2016). S. pneumoniae antigen testing was performed on the CSF samples collected from the suspected pneumococcal meningitis using lateral flow assay (Alere, USA). The isolated N. meningitidis was serotyped with a commercially kit according to the instruction (Remel, UK).
The nucleic acid was extracted using MagNA Pure 96 System (Roche) and followed by detection of 12 pathogens using Real-time PCR assays. The oligonucleotide primers and probes were listed in Table 1. S. pneumoniae, H. influenzae, GBS, E. coli, N. meningitidis, and L. monocytogenes were detected using GoTaq Probe qPCR Master Mix (Promega, USA). The final concentration for each forward primer, reverse primer, and probe was 0.2 μM, 0.2 μM, and 0.05 μM, respectively. The cycling conditions were as follows: 2 min at 95°C followed by 40 cycles of 15 s at 95°C, 1 min at 60°C. Enterovirus, HSV, JEV, mumps virus (MuV), adenovirus (AdV), and VZV were detected using QuantiTect Probe RT-PCR Kit (Qiagen, Germany) according to the instruction. The final concentration for each forward primer, reverse primer, and probe was 0.4 μM, 0.4 μM, and 0.1 μM, respectively. The cycling conditions included reverse transcription of 30 min at 50°C, a initiating stage of 15 min at 95°C, and followed by 45 cycles of 15 s at 94°C, 1 min at 60°C. The nucleic acids extracted from reference strains, constructed plasmids, or in vitro transcribed RNA templates were used as controls. Amplification, detection, and data analysis were performed in a Bio-Rad CFX96 real-time thermal cycler (Bio-Rad, USA).
Next generation sequencing
The nucleic acids of N. meningitidis strains were extracted using QIAamp DNA Mini Kit (Qiagen, Germany) and 1 μg of DNA was broken using ultrasound, concentrated, and used for preparing DNA library using NEB Next® Ultra™ DNA Library Prep Kit for Illumina (NEB, USA). Whole genome sequencing was performed on Illumina Miseq (USA). The sequencing results were edited and assembled using SPAdes and PubMLST was used for identifying alleles for multilocus sequence typing (MLST), antimicrobial resistance related genes including gyrA, penA, and rpoB, and peptide coding gene such as porA, porB, fetA, and fHbp.
A total of 634 possible childhood AMES cases were identified during June, 2015 and October, 2018 and 240 CSF samples collected from 171 patients (male, 116) were included (Fig. 1). Of all the samples, 104 sequential samples were collected from 35 patients. Twelve of samples were collected before the use of antibiotics. Patients ranged in age from 0 to 15 years old and 91 of them aged less than 3 months. Of all the patients, 73 were neonates and 27 were preterm; 103 were hospitalized or transferred from other hospitals. The most common symptoms were fever (137, 80.1%), vomiting (73, 42.7%), and seizures (36, 21.1%). Two recurrent cases were found. Thirteen cases were transferred to other hospitals and the symptoms of all the others improved when discharged from SCH. No death was found.
Overall, a pathogen was found in 85 (49.7%) cases. A bacterial pathogen was found in 68 (39.8%) of cases (GBS, 17; E. coli, 15; S. pneumoniae, 14; H. influenzae, 1; N. meningitidis, 1; others, 23). Of the other bacteria, Staphylococcus epidermidis was the predominant microorganism (9 cases) and all were isolated from patients during hospitalization and after administration of antibiotics. EV and HSV were found in 13 and 3 cases of viral infections, respectively. Candida famata was isolated from the blood sample from a neonate (Table 2). No L. monocytogenes, JEV, MuV, AdV, and VZV were detected.
GBS and Pseudomonas aeruginosa was isolated from a long-hospitalized case in the 1st and 9th month, respectively. Of the recurrent cases, S. pneumoniae was found in 2 episodes of meningitis in case 1. S. pneumoniae and E. coli was found in 1st and 2nd episode of meningitis in case 2, respectively.
Age distribution of the main pathogens
GBS and E. coli were the predominant causes of bacterial meningitis in neonates. Twelve of 17 GBS and 6 of 15 E. coli meningitis were found in neonates aged less than 1 month. All the pneumococcal meningitis was detected in patients more than 3 months old and 13 of 14 cases was found in the age group of 3 months and 5 years old. Of the 13 cases of encephalitis caused by EV, 12 was found in children over 1 years old and 8 over 5 years old. Two of 3 HSV encephalitis cases were 2 months old.
CSF examination in AMES caused by common pathogens
The mean white blood cell (WBC) count (106/μl), protein, and glucose in CSF, and hospitalization length in EV encephalitis was 143, 0.40 g/L, 3.23 mmol/L, and 7 days, respectively. A higher mean CSF WBC count and protein, longer hospitalization days, and lower CSF glucose were seen in the bacterial meningitis cases. A positive PCR result for HSV could be found in the CSF sample after 43 days of treatment. The longest period after treatment to obtain a positive PCR result for E. coli, N. meningitidis, S. pneumoniae, and GBS was 13, 8, 17, and 9 days, respectively.
Antimicrobial susceptibility profiles of the main microorganisms
Of the 4 tested isolates of S. pneumoniae, three were resistant to tetracycline, penicillin, and trimethoprim/sulfamethoxazole. All the 9 GBS isolates were resistant to clindamycin and tetracycline. Of the 4 GBS strains whose resistance to roxithromycine, azithromycin, and clarithromycin was tested, they were all resistant to these drugs (not shown). The highest resistance rate in E. coli was found in ampicillin (9/12), followed by trimethoprim/sulfamethoxazole (8/12). Resistance to penicillin, and oxacillin was found in all the 8 tested S. epidermidis isolates (Table 3).
Characterization of N. meningitidis
A serogroup B N. meningitidis was isolated from the blood sample of a 3-month-old meningococcal case. It was also detected in the CSF samples by PCR (Table 2). The isolate was sensitive to meropenem, ceftriaxone, chloramphenicol, and cefotaxime, and intermediate sensitive to penicillin. The whole genome was 2,305,805 bp and the MLST type was ST-3200/CC4821. The allele for the antibiotic-associated gene gyrA, penA, and rpoB was 116, 1, and 85, respectively. The allele for peptide coding gene porA, porB, fetA, and fHbp was 20,14; 34; F3–9; and 16/A19, respectively.
A pathogen was identified in 85 (49.7%) cases and their age distribution and prevalence of antibiotic resistance were elucidated. These results could provide basis for designing prevention policy, as well as for the diagnosis and empirical treatment of AMES. Therefore, to enable the timely and appropriate treatment and to improve the outcome.
Compared with 2.2% in a large surveillance study in which only the laboratory confirmed S. pneumoniae, H. influenzae type b, and N. meningitidis isolates were included , the detection rate in our study was greatly improved. In another study where serological tests were used for detecting viruses, a causative agent was found in 22.6% (538/2382) of cases . The use of PCR method and childhood population might contribute to the relative higher detection rate in this study. The absence of JEV, MuV, and VZV might due to the difference in sample size, regional or demographic factors. The changes of immunization policies might also affect the results, such as the low detection rate of JEV.
Despite of the usefulness of conventional methods, incorporation of PCR method could improve the outcome of surveillance. In the culture negative samples, additional 13 EV, 3 HSV, 2 GBS, and 1 H. influenzae were identified. The incidence of H. influenzae meningitis was very low due to the use of Hib vaccine in Shenzhen and it would not be considered without a positive result. The positive PCR result could help initiate timely and appropriate therapy in the clinical setting. However, due to the long course of AMES and early initiation of empirical treatment, 228 of 240 CSF samples were collected after the use of antibiotics. The presence of antibiotics in CSF might shorten the time for the detection of pathogens by PCR. In the sequential samples, the negative results were obtained after administrating antibiotics for a period of time, which was also observed in another study .
Due to the nationwide vaccination of meningococcal and JEV vaccines, the annual incidence of meningococcal disease and JE in Shenzhen decreased to 0.048 and 0.664 (per 100,000), respectively [14, 15]. The absence of JE in this study could be attributed to its low incidence. The detection of serogroup B N. meningitidis was attributed to the group specificity of meningococcal polysaccharide vaccine and its low cross-immunity rate. The introduction of meningococcal A vaccine in 2000 and meningococcal A plus C polysaccharide vaccine in 2008 in Guangdong has led to serogroup replacement of N. meningitidis. During 2008 and 2010, serogroup C meningococcal diseases (MenC) accounted for majority of meningococcal cases, and serogroup B meningococcal diseases (MenB) occurred relatively infrequently. From 2011 onwards, the proportion of MenC cases began to decline and MenB to rise [8, 16, 17]. Other strains with the same MLST type were isolated in France, UK, and Taiwan, which caused meningococcal disease mainly in young children aged less than 1 years old .
GBS was one of the predominant causes of bacterial meningitis in infants<3 months, despite of the high coverage of prenatal screening in Shenzhen. The high incidence of GBS meningitis in this age group was also observed in the UK , which was unchanged from a decade ago , suggesting the poor impact of the prevention strategy. Therefore, a better policy for prevention is urgent. The GBS isolates were susceptible to most antibiotics, but showed a high resistance rate to clindamycin and tetracycline, which was consistent with other study . The antimicrobial susceptibility profile should be considered in the empirical treatment of GBS meningitis.
Coagulase-negative Staphylococcus (CoNS), mainly S. epidermidis was one of the most commonly isolated bacteria. However, it was excluded in other studies due to its colonization on the skin surface . A contamination was not able to be discarded in the 13 CoNS isolates from CSF or blood samples. However, all the 9 S. epidermidis strains were isolated from hospitalized cases after the use of antibiotics, suggesting the possibility of nosocomial infections. The high incidence and occurrence of multi-drug resistance strain posed the necessity for designing effective prevention strategies.
S. pneumoniae was the leading cause of bacterial meningitis in the group aged between 3 months and 5 years. The estimated annual incidence of pneumococcal meningitis was 14 per 100,000 in children between 1 month and 59 months in China . According to another research, the most common serogroups were 19F, 19A, and 14, which were covered by the 13-vulent pneumococcal conjugate vaccine (PCV13) [23, 24]. The introduction of PCV13 has resulted in significant reductions of pneumococcal meningitis caused by new serotypes . But PCV13 was not included in the National Planned Immunization schedule and the vaccination rate was unknown. To reduce the incidence of pneumococcal meningitis, the introduction of PCV13 vaccine and further long surveillance were needed. The high resistance rate to tetracycline, penicillin, and trimethoprim/sulfamethoxazole needed the confirmation with large sample size.
In the aseptic meningitis and encephalitis, EV accounted for the majority of viruses detected and 92% of EV infection was found in children over 1 year of age, in agreement with the previous study . No serious complications or deaths were found. EV PCR was not routinely performed for diagnosis of central nervous system (CNS) infections in the sentinel hospital, and there was a delay of diagnosis when the samples were transported to CDC after several days of sampling. Therefore, 11 of 13 EV was found in the samples with unknown cause. As a result, a longer mean duration of hospitalization stay (7 days) and antibiotic administration (6 days) was observed, compared with a previous study (3 and 2 days, respectively) . It was highly recommended to incorporate EV PCR into the routine test for diagnosis of CNS infection in the group at high risk.
Similarly, long mean stay was observed in HSV infections (25 days) and 2 of 3 HSV-positive cases were treated as bacterial meningitis initially. The clinical findings of Herpes simplex encephalitis (HSE) were not pathognomonic and numerous other CNS infections could mimic HSE, so it was important to identify HSV in the high-risk population. All the 3 HSE cases were found in children below 2 years old, consistent with a prior study which indicated the predisposition to HSE was tightly age-dependant . Due to the long duration of disease course, efficacy of acyclovir treatment, high mortality and severe sequelae , it was important to identify HSE. Therefore, the appropriate treatment could be given and the outcome could be improved.
This study had several limitations. Firstly, all the samples were collected from one sentinel hospital and the results may not be representative of this region. Secondly, a large proportion of CSF samples subjected to PCR detection were collected after the use of antibiotics, which might result in negative results. Thirdly, a long storage time of CSF samples has led to a delay of diagnosis. Finally, the long-term outcome was not followed and the case fatality might be underestimated. Nevertheless, due to the difficulty in collecting CSF samples from children, this was the most comprehensive data collection on the etiology of AMES in this region. This referral center received childhood AMES cases from many other centers in Shenzhen made the results reasonably representative. A prospective study involved more sentinel hospitals is anticipated to overcome these limitations.
Due to the nationwide use of serogroup A and serogroup A plus C meningococcal, and JEV vaccines, the incidence of meningococcal disease and JE is very low in Shenzhen. The main causative agents for childhood AMES were GBS, S. pneumoniae, E. coli, EV, and HSV. A better prevention strategy for GBS, the introduction of PCV13 vaccine, and incorporation of PCR methods were recommended to reduce the incidence of AMES and achieve early diagnosis.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding authors on reasonable request.
Acute meningitis and encephalitis syndrome
Center for Disease Control and Prevention
Clinical and Laboratory Standards Institute
Central nervous system
Expanded Program on Immunization
Group B Streptococcus
Herpes simplex encephalitis
Herpes simplex virus
Japanese encephalitis virus
Lateral flow assay
Serogroup B meningococcal diseases
Serogroup C meningococcal diseases
Minimum inhibitory concentration
Multilocus sequence typing
13-vulent pneumococcal conjugate vaccine
Shenzhen Children’s Hospital
Varicella zoster virus
White blood cell
Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317–28.
Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–25.
Li Y, Yin Z, Shao Z, Li M, Liang X, Sandhu HS, Hadler SC, Li J, Sun Y, Li J, et al. Population-based surveillance for bacterial meningitis in China, September 2006-December 2009. Emerg Infect Dis. 2014;20(1):61–9.
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835–44.
Zheng Y, Li M, Wang H, Liang G. Japanese encephalitis and Japanese encephalitis virus in mainland China. Rev Med Virol. 2012;22(5):301–22.
Wang H, Li Y, Liang X, Liang G. Japanese encephalitis in mainland China. Jpn J Infect Dis. 2009;62(5):331–6.
Gao X, Li X, Li M, Fu S, Wang H, Lu Z, Cao Y, He Y, Zhu W, Zhang T, et al. Vaccine strategies for the control and prevention of Japanese encephalitis in mainland China, 1951-2011. PLoS Negl Trop Dis. 2014;8(8):e3015.
Li J, Shao Z, Liu G, Bai X, Borrow R, Chen M, Guo Q, Han Y, Li Y, Taha MK, et al. Meningococcal disease and control in China: findings and updates from the global meningococcal initiative (GMI). J Inf Secur. 2018;76(5):429–37.
Li J, Li Y, Shao Z, Li L, Yin Z, Ning G, Xu L, Luo H. Prevalence of meningococcal meningitis in China from 2005 to 2010. Vaccine. 2015;33(8):1092–7.
Xie Y, Tan Y, Chongsuvivatwong V, Wu X, Bi F, Hadler SC, Jiraphongsa C, Sornsrivichai V, Lin M, Quan Y. A population-based acute meningitis and encephalitis syndromes surveillance in Guangxi, China, may 2007-June 2012. PLoS One. 2015;10(12):e0144366.
Sacchi CT, Fukasawa LO, Goncalves MG, Salgado MM, Shutt KA, Carvalhanas TR, Ribeiro AF, Kemp B, Gorla MC, Albernaz RK, et al. Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in Sao Paulo, Brazil. PLoS One. 2011;6(6):e20675.
Chiba N, Murayama SY, Morozumi M, Nakayama E, Okada T, Iwata S, Sunakawa K, Ubukata K. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. J Infect Chemother. 2009;15(2):92–8.
Saha SK, Darmstadt GL, Yamanaka N, Billal DS, Nasreen T, Islam M, Hamer DH. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J. 2005;24(12):1093–8.
Qin Y, Mei S, Xie X, Kong D, Tang X. Analysis of the epidemiological characteristics of epidemic cerebrospinal meningitis in Shenzhen during 2005-2015. J Dis Monitor Control. 2016;10(11):874–5 (in Chinese).
Xu L, Xie J, Li Y. Analysis on epidemic characteristics of epidemic encephalitis B in Baoan District of Shenzhen. Pract Prev Med. 2009;16(1):64–5 (in Chinese).
Z-j S, Xu L, Gao Y. Epidemiologic trend of serogroup switching of Neisseria meningitidis strains in China [J]. Chin J Vaccines Immunization. 2007;6:012 (in Chinese).
Zhou H, Liu W, Xu L, Deng L, Deng Q, Zhuo J, Shao Z. Spread of Neisseria meningitidis serogroup W clone, China. Emerg Infect Dis. 2013;19(9):1496–9.
Chiou CS, Liao JC, Liao TL, Li CC, Chou CY, Chang HL, Yao SM, Lee YS. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect Dis. 2006;6:25.
Okike IO, Johnson AP, Henderson KL, Blackburn RM, Muller-Pebody B, Ladhani SN, Anthony M, Ninis N, Heath PT, neoMen Study G. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis. 2014;59(10):e150–7.
Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O'Connell LA, Cafferkey M, Verlander NQ, Nicoll A, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004;363(9405):292–4.
Zhang J, Zhao R, Dong Y, Zheng Y. Invasive group B streptococcal infection in infants in Shenzhen, China. Int J Clin Exp Med. 2015;8(2):2939–43.
Cho HK, Lee H, Kang JH, Kim KN, Kim DS, Kim YK, Kim JS, Kim JH, Kim CH, Kim HM, et al. The causative organisms of bacterial meningitis in Korean children in 1996-2005. J Korean Med Sci. 2010;25(6):895–9.
Chen Y, Deng W, Wang SM, Mo QM, Jia H, Wang Q, Li SG, Li X, Yao BD, Liu CJ, et al. Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review. PLoS One. 2011;6(11):e27333.
Ma X, Zhao R, Ma Z, Yao K, Yu S, Zheng Y, Yang Y. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive diseases from Shenzhen Children's hospital. PLoS One. 2013;8(6):e67507.
Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine. 2011;29(49):9127–31.
Michos AG, Syriopoulou VP, Hadjichristodoulou C, Daikos GL, Lagona E, Douridas P, Mostrou G, Theodoridou M. Aseptic meningitis in children: analysis of 506 cases. PLoS One. 2007;2(7):e674.
Abel L, Plancoulaine S, Jouanguy E, Zhang SY, Mahfoufi N, Nicolas N, Sancho-Shimizu V, Alcais A, Guo Y, Cardon A et al: Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J Pediatr 2010, 157(4):623–629, 629 e621.
Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002;359(9305):507–13.
Azzari C, Moriondo M, Indolfi G, Massai C, Becciolini L, de Martino M, Resti M. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol. 2008;57(Pt 10):1205–12.
Gillespie BE, Oliver SP. Simultaneous detection of mastitis pathogens, Staphylococcus aureus, Streptococcus uberis, and Streptococcus agalactiae by multiplex real-time polymerase chain reaction. J Dairy Sci. 2005;88(10):3510–8.
Maheux AF, Bissonnette L, Boissinot M, Bernier JL, Huppe V, Picard FJ, Berube E, Bergeron MG. Rapid concentration and molecular enrichment approach for sensitive detection of Escherichia coli and Shigella species in potable water samples. Appl Environ Microbiol. 2011;77(17):6199–207.
Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39(4):1553–8.
Flekna G, Stefanic P, Wagner M, Smulders FJ, Mozina SS, Hein I. Insufficient differentiation of live and dead campylobacter jejuni and listeria monocytogenes cells by ethidium monoazide (EMA) compromises EMA/real-time PCR. Res Microbiol. 2007;158(5):405–12.
Uchida K, Shinohara M, Shimada S, Segawa Y, Doi R, Gotoh A, Hondo R. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J Med Virol. 2005;75(3):470–4.
Kessler HH, Muhlbauer G, Rinner B, Stelzl E, Berger A, Dorr HW, Santner B, Marth E, Rabenau H. Detection of herpes simplex virus DNA by real-time PCR. J Clin Microbiol. 2000;38(7):2638–42.
Shirato K, Miyoshi H, Kariwa H, Takashima I. Detection of West Nile virus and Japanese encephalitis virus using real-time PCR with a probe common to both viruses. J Virol Methods. 2005;126(1–2):119–25.
Piqueur MA, Verstrepen WA, Bruynseels P, Mertens AH. Improvement of a real-time RT-PCR assay for the detection of enterovirus RNA. Virol J. 2009;6:95.
Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003;70(2):228–39.
Weidmann M, Meyer-Konig U, Hufert FT. Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR. J Clin Microbiol. 2003;41(4):1565–8.
We thank the staff from the clinical laboratory of Shenzhen Children’s Hospital who took part in the study. We thank the great help offered by Mr. Muhammad Luqman in manuscript revision.
This study was supported by grants from the China Mega-Project for Infectious Disease (2017ZX10302301–004 and 2017ZX10104001); Medical Scientific Research Foundation of Guangdong Province (A2017143); Shenzhen Science and Technology Innovation Committee (JCYJ20160428152017475); Health and Family Planning Commission of Shenzhen Municipality (201602009, 201601040); and Futian District Public Health Research Project (FTWS2016049).
These funding supported the collection and detection of clinical samples, analysis of data, and publication.
Ethics approval and consent to participate
All aspects of the study were performed in accordance with national ethics regulations and approved by the Ethics Committee of Shenzhen Children’s Hospital and Futian District Center for Disease Control and Prevention. Written consent was obtained from children’s parents or guardians.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.